| Product Code: ETC11227213 | Publication Date: Apr 2025 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
The import shipments of type 2 diabetes drugs and devices to New Zealand in 2024 were primarily sourced from key countries like Australia, Metropolitan France, Spain, Ireland, and Germany. Despite the low Herfindahl-Hirschman Index (HHI) indicating a diverse market, the industry experienced a modest Compound Annual Growth Rate (CAGR) of 3.11% from 2020 to 2024. However, there was a noticeable decline in growth rate from 2023 to 2024 at -16.18%, suggesting a potential shift in market dynamics or temporary factors influencing the industry`s performance in that period.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 New Zealand Type 2 Diabetes Drugs and Devices Market Overview |
3.1 New Zealand Country Macro Economic Indicators |
3.2 New Zealand Type 2 Diabetes Drugs and Devices Market Revenues & Volume, 2022 & 2032F |
3.3 New Zealand Type 2 Diabetes Drugs and Devices Market - Industry Life Cycle |
3.4 New Zealand Type 2 Diabetes Drugs and Devices Market - Porter's Five Forces |
3.5 New Zealand Type 2 Diabetes Drugs and Devices Market Revenues & Volume Share, By Type, 2022 & 2032F |
3.6 New Zealand Type 2 Diabetes Drugs and Devices Market Revenues & Volume Share, By Drug Class, 2022 & 2032F |
3.7 New Zealand Type 2 Diabetes Drugs and Devices Market Revenues & Volume Share, By Device Type, 2022 & 2032F |
3.8 New Zealand Type 2 Diabetes Drugs and Devices Market Revenues & Volume Share, By End Use, 2022 & 2032F |
4 New Zealand Type 2 Diabetes Drugs and Devices Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of type 2 diabetes in New Zealand |
4.2.2 Rising awareness about diabetes management and treatment options |
4.2.3 Technological advancements in diabetes drugs and devices |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval |
4.3.2 High cost associated with diabetes drugs and devices |
4.3.3 Limited access to healthcare services in some regions of New Zealand |
5 New Zealand Type 2 Diabetes Drugs and Devices Market Trends |
6 New Zealand Type 2 Diabetes Drugs and Devices Market, By Types |
6.1 New Zealand Type 2 Diabetes Drugs and Devices Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 New Zealand Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By Type, 2022 - 2032F |
6.1.3 New Zealand Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By Oral Drugs, 2022 - 2032F |
6.1.4 New Zealand Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By Injectables, 2022 - 2032F |
6.1.5 New Zealand Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By Insulin Therapy, 2022 - 2032F |
6.1.6 New Zealand Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By Combination Therapy, 2022 - 2032F |
6.2 New Zealand Type 2 Diabetes Drugs and Devices Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 New Zealand Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By Metformin, 2022 - 2032F |
6.2.3 New Zealand Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By SGLT2 Inhibitors, 2022 - 2032F |
6.2.4 New Zealand Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By GLP-1 Agonists, 2022 - 2032F |
6.2.5 New Zealand Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By DPP-4 Inhibitors, 2022 - 2032F |
6.3 New Zealand Type 2 Diabetes Drugs and Devices Market, By Device Type |
6.3.1 Overview and Analysis |
6.3.2 New Zealand Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By Glucose Monitors, 2022 - 2032F |
6.3.3 New Zealand Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By Insulin Pumps, 2022 - 2032F |
6.3.4 New Zealand Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By CGMs, 2022 - 2032F |
6.3.5 New Zealand Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By Smart Insulin Pens, 2022 - 2032F |
6.4 New Zealand Type 2 Diabetes Drugs and Devices Market, By End Use |
6.4.1 Overview and Analysis |
6.4.2 New Zealand Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By Hospitals, 2022 - 2032F |
6.4.3 New Zealand Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By Clinics, 2022 - 2032F |
6.4.4 New Zealand Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By Pharmacies, 2022 - 2032F |
6.4.5 New Zealand Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By Home Care, 2022 - 2032F |
7 New Zealand Type 2 Diabetes Drugs and Devices Market Import-Export Trade Statistics |
7.1 New Zealand Type 2 Diabetes Drugs and Devices Market Export to Major Countries |
7.2 New Zealand Type 2 Diabetes Drugs and Devices Market Imports from Major Countries |
8 New Zealand Type 2 Diabetes Drugs and Devices Market Key Performance Indicators |
8.1 Patient adherence rate to prescribed diabetes medications |
8.2 Rate of adoption of advanced diabetes management technologies |
8.3 Percentage of healthcare professionals trained in diabetes care and treatment |
8.4 Number of diabetes-related research studies and clinical trials conducted |
8.5 Percentage of diabetic patients achieving target HbA1c levels |
9 New Zealand Type 2 Diabetes Drugs and Devices Market - Opportunity Assessment |
9.1 New Zealand Type 2 Diabetes Drugs and Devices Market Opportunity Assessment, By Type, 2022 & 2032F |
9.2 New Zealand Type 2 Diabetes Drugs and Devices Market Opportunity Assessment, By Drug Class, 2022 & 2032F |
9.3 New Zealand Type 2 Diabetes Drugs and Devices Market Opportunity Assessment, By Device Type, 2022 & 2032F |
9.4 New Zealand Type 2 Diabetes Drugs and Devices Market Opportunity Assessment, By End Use, 2022 & 2032F |
10 New Zealand Type 2 Diabetes Drugs and Devices Market - Competitive Landscape |
10.1 New Zealand Type 2 Diabetes Drugs and Devices Market Revenue Share, By Companies, 2025 |
10.2 New Zealand Type 2 Diabetes Drugs and Devices Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here